Get Cash Back and $0 Commissions
+ The Power of TradeStation

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Apexigen, Inc. Buyout

Newsfile 25-May-2023 9:59 AM

Wilmington, Delaware--(Newsfile Corp. - May 25, 2023) - Rigrodsky Law, P.A. is investigating Apexigen, Inc. ("Apexigen") (NASDAQ:APGN) regarding possible breaches of fiduciary duties and other violations of law related to Apexigen's agreement to be acquired by Pyxis Oncology, Inc. ("Pyxis"). Under the terms of the agreement, Apexigen shareholders will receive 0.1725 shares of Pyxis per share.

To learn more about this investigation and your rights, visit:

To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

Rigrodsky Law, P.A.
Seth D. Rigrodsky, Esq.
Gina M. Serra, Esq.
Call or Text: (302) 295-5310

To view the source version of this press release, please visit

Image for Press Release 1708282